Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Sen Susan Collins (R, Me) praised a new proposed rule by the Department of Health and Human Services (HHS) that would increase the number of patients with opioid use disorders qualified physicians can treat with buprenorphine, a μ-opioid receptor partial agonist approved for clinical use by the Food and Drug Administration in 2002 (http://1.usa.gov/1XZUhq2).
Qualified physicians are those who have received a waiver from the Substance Abuse and Mental Health Services Administration and the Drug Enforcement Agency to prescribe buprenorphine. In addition, they must possess subspecialty board certification in addiction medicine or addiction psychiatry or work in a qualified practice setting.
Rubin R. Doubling Cap on Patients Physicians Can Treat With Buprenorphine. JAMA. 2016;315(18):1938. doi:10.1001/jama.2016.4569
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: